CN1223377C - 甲型肝炎灭活疫苗吕8快株的选育和制备方法 - Google Patents
甲型肝炎灭活疫苗吕8快株的选育和制备方法 Download PDFInfo
- Publication number
- CN1223377C CN1223377C CNB021339260A CN02133926A CN1223377C CN 1223377 C CN1223377 C CN 1223377C CN B021339260 A CNB021339260 A CN B021339260A CN 02133926 A CN02133926 A CN 02133926A CN 1223377 C CN1223377 C CN 1223377C
- Authority
- CN
- China
- Prior art keywords
- strain
- generation
- days
- hepatitis
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000005252 hepatitis A Diseases 0.000 title claims abstract description 16
- 229940031551 inactivated vaccine Drugs 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 241000700605 Viruses Species 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 238000009395 breeding Methods 0.000 claims description 6
- 210000002950 fibroblast Anatomy 0.000 claims description 6
- 210000004072 lung Anatomy 0.000 claims description 6
- 239000013553 cell monolayer Substances 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 244000309466 calf Species 0.000 claims description 3
- 210000003608 fece Anatomy 0.000 claims description 3
- 229930027917 kanamycin Natural products 0.000 claims description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 3
- 229960000318 kanamycin Drugs 0.000 claims description 3
- 229930182823 kanamycin A Natural products 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 230000003442 weekly effect Effects 0.000 claims description 3
- 238000011534 incubation Methods 0.000 claims description 2
- 239000000427 antigen Substances 0.000 abstract description 7
- 102000036639 antigens Human genes 0.000 abstract description 7
- 108091007433 antigens Proteins 0.000 abstract description 7
- 230000005847 immunogenicity Effects 0.000 abstract description 3
- 230000002349 favourable effect Effects 0.000 abstract 3
- 238000012258 culturing Methods 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 241001515942 marmosets Species 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 231100000820 toxicity test Toxicity 0.000 abstract 1
- 241000709721 Hepatovirus A Species 0.000 description 13
- 238000011081 inoculation Methods 0.000 description 10
- 229940124724 hepatitis-A vaccine Drugs 0.000 description 6
- 241000282693 Cercopithecidae Species 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000011218 seed culture Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 241000288950 Callithrix jacchus Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012297 crystallization seed Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
检定项目 | 25代吕8株 26代吕8株 |
无菌实验 | 合格 合格 |
感染性滴度Log TCID50/ml | 8.33 7.77 |
HAV抗原滴度 | 1∶256 1∶512 |
中和试验 | 均能被特异抗体中和 |
鉴别试验 | HAV抗原阳性 HAV抗原阳性 |
结论 | 具有甲型肝炎病毒特征 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021339260A CN1223377C (zh) | 2002-10-17 | 2002-10-17 | 甲型肝炎灭活疫苗吕8快株的选育和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021339260A CN1223377C (zh) | 2002-10-17 | 2002-10-17 | 甲型肝炎灭活疫苗吕8快株的选育和制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1490053A CN1490053A (zh) | 2004-04-21 |
CN1223377C true CN1223377C (zh) | 2005-10-19 |
Family
ID=34145716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021339260A Expired - Lifetime CN1223377C (zh) | 2002-10-17 | 2002-10-17 | 甲型肝炎灭活疫苗吕8快株的选育和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1223377C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103525770B (zh) * | 2013-10-08 | 2015-08-19 | 云南沃森生物技术股份有限公司 | 人胚肺成纤维细胞株在制备甲肝疫苗中的应用 |
-
2002
- 2002-10-17 CN CNB021339260A patent/CN1223377C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1490053A (zh) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101402944B (zh) | 一种ev-71病毒毒种、人用灭活疫苗及其制备方法 | |
CN104099301B (zh) | 柯萨奇病毒a16型病毒株、用途、疫苗及其制备方法 | |
CN101695570A (zh) | 一种手足口病单、双价灭活疫苗及其制备方法 | |
CN102911910A (zh) | 人胚肺成纤维细胞株及利用其生产手足口病毒疫苗的方法 | |
CN102618505B (zh) | 人轮状病毒毒种ztr-68毒株及其分离,培养与鉴定 | |
CN101524536B (zh) | 人胚肺成纤维细胞乙型脑炎疫苗及其制备方法 | |
CN100513559C (zh) | 新的水痘病毒毒株、水痘减毒活疫苗及其制备方法 | |
CN101161286B (zh) | 水痘减毒活疫苗 | |
CN102805862B (zh) | 一种vero细胞培养新布尼亚病毒纯化灭活疫苗的制备方法 | |
CN1223377C (zh) | 甲型肝炎灭活疫苗吕8快株的选育和制备方法 | |
CN1966075A (zh) | 一种人用乙型脑炎灭活疫苗及其制备方法 | |
CN103160475B (zh) | 一种肠道病毒71型病毒株及其用途、疫苗和制备方法 | |
CN1029239C (zh) | 甲型肝炎疫苗的生产方法 | |
CN102757941B (zh) | 甲型肝炎病毒株hav-zl2012,由其制备得到的疫苗及应用 | |
CN102174477B (zh) | 甲型肝炎病毒株sh及其二倍体细胞适应方法 | |
CN103160474B (zh) | 肠道病毒71型病毒株、疫苗、动物模型建立方法 | |
CN1216985C (zh) | 甲型肝炎病毒毒株,制备甲肝灭活疫苗的方法及所得疫苗 | |
CN102805863B (zh) | 一种人二倍体细胞培养新布尼亚病毒纯化灭活疫苗的制备方法 | |
CN105713855A (zh) | 菌株及其应用,以及疫苗及其制备方法 | |
CN101525597B (zh) | 新的甲型肝炎灭活疫苗病毒毒株及其培养方法 | |
CN115429876A (zh) | 一种预防手足口病的联合疫苗及其制备方法和应用 | |
CN1128218C (zh) | 可致成人腹泻的新轮状病毒(Rotavirus)及其培养方法 | |
CN112791179B (zh) | 一种预防手足口病的联合疫苗及其制备方法和应用 | |
CN118272316A (zh) | 手足口病疫苗及其制备方法和应用 | |
CN104694486B (zh) | 一种二联手足口病灭活疫苗及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: KUNMING SHANGCHENG BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: MEDICAL BIOLOGY INST., CHINESE ACADEMY OF MEDICAL SCIENCES Effective date: 20100723 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650118 NO.379, JIAOLING ROAD, KUNMING CITY, YUNNAN PROVINCE TO: 650118 ROOM 503, BUILDING A2, ERQI, STATE COLLEGE SCIENCE PARK, KUNMING CITY HIGH-TECH ZONE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100723 Address after: 650118 A2 building 503, National University Science Park, Kunming hi tech Zone, 2 Patentee after: Kunming Cheng Cheng Biotechnology Co.,Ltd. Address before: Jiao Ling Road 650118 Yunnan city of Kunming Province, No. 379 Patentee before: INSTITUTE OF MEDICAL BIOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES |
|
ASS | Succession or assignment of patent right |
Owner name: KUNMING SHENGFEI BIO-PHARMACEUTICAL TECHNOLOGY CO. Free format text: FORMER OWNER: KUNMING SHANGCHENG BIOTECHNOLOGY CO., LTD. Effective date: 20100826 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650118 ROOM 503, BUILDING A2, PHASE 2, NATIONAL UNIVERSITY SCIENCE AND TECHNOLOGY PARK, KUNMING HIGH-TECH. ZONE TO: 650118 ROOM 501, BUILDING A2, PHASE 2, NATIONAL UNIVERSITY SCIENCE AND TECHNOLOGY PARK, KUNMING HIGH-TECH. ZONE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20100826 Address after: 650118 A2 building 501, National University Science Park, Kunming hi tech Zone, 2 Patentee after: Kunming Sheng Fei biological medicine technology Co.,Ltd. Address before: 650118 A2 building 503, National University Science Park, Kunming hi tech Zone, 2 Patentee before: Kunming Cheng Cheng Biotechnology Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JIANGSU CONVAC BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: KUNMING SHENGFEI BIOMEDICAL TECHNOLOGY CO., LTD. Effective date: 20130516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: KUNMING, YUNNAN PROVINCE TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130516 Address after: 225300 drug city, Taizhou hi tech Zone, Jiangsu Province Patentee after: JIANGSU CONVAC BIO-TECHNOLOGY Co.,Ltd. Address before: Room 501, building A2, 2, National University Science Park, Kunming hi tech Zone Patentee before: Kunming Sheng Fei biological medicine technology Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20180517 Address after: No. 819, drug City Avenue, Taizhou, Jiangsu Province, Jiangsu Patentee after: AIMEI CONVAC BIO-PHARMACY (JIANGSU) Co.,Ltd. Address before: 225300 drug city road, Jiangsu medical and Technological Development Zone, Taizhou Patentee before: JIANGSU CONVAC BIO-TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20051019 |